Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 1, 2011, Pages 164-170

  Stefanescu, Horia ^a   Grigorescu, Mircea ^a   Lupsor, Monica ^a   Procopet, Bogdan ^a   Maniu, Anca ^a   Badea, Radu ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Esophageal varices; Liver cirrhosis; Noninvasive; Spleen stiffness; Transient elastography

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ELASTOGRAPHY; ENDOSCOPY; ESOPHAGUS VARICES; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MEASUREMENT; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SPLEEN STIFFNESS MEASUREMENT;

EID: 78650377222     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06325.x     Document Type: Article

References (34)

1. Bosch J, Garcia-Pagan JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin. Liver Dis. 2006; 26: 348-62.
2. Wai CT, Greenson JL, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
3. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of esophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-5.
4. Bolognesi M, Boscato N. Spleen and liver cirrhosis: relationship between spleen enlargement and portal hypertension in patients with liver cirrhosis. In: Chen TM, ed. New Developments in Liver Cirrhosis Research. Hauppauge, NY: Nova Science Publishers, 2006; 49-67.
5. Bolognesi M, Merkel C, Sacerdoti D, Nava V, Gatta A. The role of spleen enlargement in cirrhosis with portal hypertension. Dig. Liver Dis. 2002; 34: 144-50.
6. Kuddus RH, Nalesnik MA, Subbotin VM, Rao AS, Gandhi CR. Enhanced synthesis and reduced metabolism of endothelin 1 (ET-1) by hepatocytes-an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. J. Hepatol. 2000; 33: 725-32.
7. Yin M, Talwalkar JA, Glaser KJ. A preliminary assessment of hepatic fibrosis with magnetic resonance elastography. Clin. Gastroenterol. Hepatol. 2007; 5: 1207-13.e2.
8. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound. Med. Biol. 2003; 29: 1705-13.
9. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
10. Foucher J, Chanteloup E, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
11. Ganne-Carrie N, Ziol M, de Ledinghen V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-17.
12. Lupsor M, Badea R, Stefanescu H et al. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients. J. Gastrointestin. Liver Dis. 2008; 17: 155-63.
13. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl. 2006; 12: 1791-8.
14. Bureau C, Metivier S, Peron JM et al. Prospective assessment of liver stiffness for the non-invasive prediction of portal hypertension (abstract). J. Hepatol. 2007; 46: S34.
15. Lemoine M, Katsahian S, Nahon P et al. Liver stiffness measurement is correlated with hepatic venous pressure gradient in patients with uncomplicated alcoholic and/or HCV related cirrhosis (abstract). Hepatology 2006; 44: 204A.
16. Vizzutti F, Arena U, Romanelli RG et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007; 45: 1290-7.
17. Stefanescu H, Lupsor M, Grigorescu M, Procopet B, Maniu A, Badea R. Transient elastography of the spleen as non-invasive assessment of portal hypertension in liver cirrhosis patients. Poster abstract nr 63, Proceedings of EASL Monothematic Conference Portal Hypertension: Advances in Knowledge, Evaluation and Management, Budapest, 2009, p. 130.
18. Di Marco V, Bronte F, Calvaruso V et al. Fibrospleen: measuring spleen stiffness by transient elastography increases accuracy of staging liver fibrosis and of portal hypertension in chronic viral hepatitis (abstract). Dig. Liver Dis. 2009; 41: A38.
19. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol. 2008; 48: 835-47.
20. Kettaneh A, Marcellin P, Douvin C et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J. Hepatol. 2007; 46: 628-34.
21. Merkel C, Gatta A, Arnaboldi L, Zuin R. Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin. Physiol. 1985; 5: 531-9.
22. Sheth SG, Amarapurkar DN, Chopra KB, Mani SA, Mehta PJ. Evaluation of splenomegaly in portal hypertension. J. Clin. Gastroenterol. 1996; 22: 28-30.
23. Kreel L, Williams RA. Arterior-venography of the portal system. Br. Med. J. 1964; 2: 1500-3.
24. Manenti A, Botticelli A, Gibertini G, Botticelli L. Experimental congestive splenomegaly: histological observations in rats. Pathologica 1993; 85: 721-4.
25. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated stellate cells. Gastroenterology 1996; 110: 534-48.
26. Gibson PR, Gibson RN, Dithfield MR, Donlan JD. Splenomegaly-an insensitive sign of portal hypertension. Aust. N. Z. J. Med. 1990; 20: 326-45.
27. Bolognesi M, Sacerdoti D, Bombonato G et al. Changes in portal flow after liver transplantation: effect an hepatic arterial resistance indices and role of spleen size. Hepatology 2002; 35: 601-8.
28. Talwalkar J. Evaluation of fibrosis and portal hypertension: non-invasive assessment. Oral presentation abstract, Proceedings of EASL Monothematic Conference Portal Hypertension: Advances in Knowledge, Evaluation and Management, Budapest, 2009, p. 47.
29. Castera L, LeBail B, Roudot-Thoraval F et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J. Hepatol. 2009; 50: 59-68.
30. Kazemi F, Kettaneh A, N'Kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large esophageal varices. J. Hepatol. 2006; 45: 230-5.
31. Bosch J. Predictions from a hard liver. J. Hepatol. 2006; 45: 174-7.
32. Bureau C, Metivier S, Peron JM et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment. Pharmacol. Ther. 2008; 27: 1261-8.
33. Gianini EG, Zaman A, Kreil A et al. Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am. J. Gastroenterol. 2006; 101: 2511-19.
34. Schwartzenberg E, Meyer T, Golla V, Sahdala NP, Min AD. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. J. Clin. Gastroenterol. 2010; 44: 146-50.